Log in

OTCMKTS:GLAPYGlanbia Stock Price, Forecast & News

$54.36
0.00 (0.00 %)
(As of 04/5/2020 03:35 AM ET)
Add
Compare
Today's Range
$54.36
Now: $54.36
$54.36
50-Day Range
$51.43
MA: $57.74
$60.73
52-Week Range
$51.43
Now: $54.36
$101.00
Volume84 shs
Average Volume30 shs
Market Capitalization$3.22 billion
P/E Ratio10.12
Dividend Yield3.13%
Beta0.27
Glanbia plc operates as a nutrition company worldwide. It operates through three segments: Glanbia Performance Nutrition, Glanbia Nutritionals, and Glanbia Ireland. The Glanbia Performance Nutrition segment manufactures and sells sports nutrition and lifestyle nutrition products in various formats, including powders, ready-to-eat bars and snacking foods, and ready-to-drink beverages through various channels, such as specialty retail, the Internet, and gyms, as well the food, drug, mass, and club channels. The Glanbia Nutritionals segment manufactures and sells cheese, dairy and non-dairy nutritional ingredients, and vitamin and mineral premixes. The Glanbia Ireland segment operates as a milk processor in Ireland; and produces a range of value added dairy ingredients and consumer products. It also sells animal nutrition and fertilizer products; and operates a chain of agricultural retail outlets in Ireland. The company also engages in the financing, research and development, property and land dealing, receivables management, management, property leasing, business service, and weight management solutions businesses. It provides its products under the Optimum Nutrition, BSN, Isopure, Nutramino, ABB, thinkThin, Amazing Grass, Body & Fit, and SlimFast brands in approximately 100 countries. The company was founded in 1964 and is headquartered in Kilkenny, Ireland.
Read More
Glanbia logo

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.2Dividend Strength: 3.3Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.48 out of 5 stars


Industry, Sector and Symbol

Industry Private households
Sub-IndustryN/A
SectorConsumer Staples
Current SymbolOTCMKTS:GLAPY
CUSIPN/A
CIKN/A
Phone353-56-777-2200

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$2.82 billion
Cash Flow$7.13 per share
Book Value$31.70 per share

Profitability

Miscellaneous

Employees6,900
Market Cap$3.22 billion
Next Earnings DateN/A
OptionableNot Optionable

Receive GLAPY News and Ratings via Email

Sign-up to receive the latest news and ratings for GLAPY and its competitors with MarketBeat's FREE daily newsletter.


Glanbia (OTCMKTS:GLAPY) Frequently Asked Questions

How has Glanbia's stock been impacted by COVID-19 (Coronavirus)?

Glanbia's stock was trading at $57.58 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, GLAPY shares have decreased by 5.6% and is now trading at $54.36. View which stocks have been mosted impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Glanbia?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Glanbia in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Glanbia.

Has Glanbia been receiving favorable news coverage?

Headlines about GLAPY stock have been trending very negative on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative news coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Glanbia earned a media sentiment score of -3.3 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the near term. View the latest news aboutGlanbia.

Who are some of Glanbia's key competitors?

What other stocks do shareholders of Glanbia own?

Who are Glanbia's key executives?

Glanbia's management team includes the following people:
  • Ms. Siobhán Talbot, Group MD & Exec. Director (Age 55)
  • Mr. Mark A. Garvey, Group Fin. Director & Exec. Director (Age 55)
  • Mr. Brian Phelan, Exec. Director & CEO of Glanbia Nutritionals (Age 52)
  • Mr. Hugh McGuire, Exec. Director & CEO of Glanbia Performance Nutrition (Age 48)
  • Mr. Liam Hennigan, Group Director of Strategic Planning & Investor Relations

What is Glanbia's stock symbol?

Glanbia trades on the OTCMKTS under the ticker symbol "GLAPY."

How do I buy shares of Glanbia?

Shares of GLAPY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Glanbia's stock price today?

One share of GLAPY stock can currently be purchased for approximately $54.36.

How big of a company is Glanbia?

Glanbia has a market capitalization of $3.22 billion and generates $2.82 billion in revenue each year. The company earns $276.35 million in net income (profit) each year or $5.37 on an earnings per share basis. Glanbia employs 6,900 workers across the globe. View additional information about Glanbia.

What is Glanbia's official website?

The official website for Glanbia is http://www.glanbia.com/.

How can I contact Glanbia?

Glanbia's mailing address is Glanbia House Ring Road, KILKENNY L2, 10048-0557. The company can be reached via phone at 353-56-777-2200 or via email at [email protected]

This page was last updated on 4/5/2020 by MarketBeat.com Staff

Featured Article: Institutional Investors

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel